FROM CHRONIC PAIN TO ACTIVE LIFE

A hope for chronic pain sufferers!

actiTENS is a non-invasive, drug-free technology for relieving pain, reducing the painkiller consumption¹ and improving quality of life for patients suffering from pain².

Discreet and versatile solution

actiTENS is a mobile and versatile solution that dynamically adapts to different physical contours and pathologies, with a wide range of fastening accessories and electrodes including multisite and low back electrodes offering a personalized and effective treatment experience for pain relief.

0 M

Stimulation sessions

0 k⁺

Active users

0 ⁺

patient accounts

Connected

actiTENS is controlled by our mobile application, enabling people to create a patient account and benefit from patient follow-up.

Ergonomic

actiTENS is a device designed to adapt perfectly to different areas of the body and their contours.

Discreet

The discreet design of actiTENS allows patients to follow their therapy program at any time.

Pain relief in your hands

With our interactive smartphone app wirelessy activate treatment, store personalized treatment data and see results of your therapy!

Programs

shows all available stimulation programs. To quickly start a stimulation session

Remote control

Allows to adjust intensity and manage stimulation settings remotely.

My health menu

Centralizes pain and stimulation session data, with the option to export a PDF report*.

Patient account

Stores personal information, tracking data, and user preferences, accessible via the app.

actiTENS in knee osteoarthritis (KOA) pain management

14 millions American citizens suffer from symptomatic KOA³.

62% of people with osteoarthritis treated in primary care had at least one comorbidity, the most common being: hypertension (37%), heart disease (8%) and diabetes (7%)⁴.

A new wearable transcutaneous electrical nerve stimulation device (actiTENS) is more efficient and better tolerated than weak opioids in the treatment of knee osteoarthritis pain⁵

actiTENS has proven to be more effective than Level 2 analgesics.

A clinical study conducted with 55 patients utilizing actiTENS for knee osteoarthritis pain management, compared to a second group of 55 patients consuming Level 2 analgesics for the same condition, revealed the following outcomes⁵.

Patients using actiTENS show a significant pain reduction of 2.06 points after 3 months, surpassing the efficacy of weak opioids

2.06 points

Mean reduction in pain intensity

Current activities

After 3 months of use, 84% of patients reported improved daily functioning based on responses collected through the Womac questionnaire⁵

actiTENS® in endometriosis pain management

Endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally⁶.

the most frequently reported symptoms of endometriosis are pelvic pain (92.5%), dyspareunia (80%) and heavy bleeding (75%)⁷.

Endometriosis has significant social, public health and economic implications. It can decrease quality of life due to severe pain, fatigue, depression, anxiety and infertility⁶.

actiTENS offers TENS and EMS mode stimulation programs designed to alleviate endometriosis pain, providing targeted relief.

actiTENS could be a relevant non-pharmacological therapeutic option for the management of pain in endometriosis

Inapp survey conducted among patients utilizing actiTENS for managing endometriosis pain has demonstrated the following outcomes: improvements in pain levels, quality of life, activity limitations, and reduced medication¹.

0 %

of patients using actiTENS reported an improvement in their pain.

0 %

of patients using actiTENS reported an improvement in their quality of life.

0 %

of patients, actiTENS results in an improvement in activity limitations.

0 %

of patients using actiTENS reported a reduction in drug consumption.

Control of actiTENS via a mobile application enables us to carry out real-life surveys with patients to assess the device's effectiveness

actiTENS vs competitors, from a patient's point of view

InApp survey conducted from 31/05 to 26/06/23 among 68 patients new users of actiTENS suffering from various pathologies and having previously used another TENS⁸.

0 %

of patients using actiTENS reported an improvement in their pain.

0 %

of patients using actiTENS consider it to be easier to use than other TENS already used.

0 %

actiTENS offers improved use of TENS therapy at work, outdoors and in daily activities for 82% of its users.

0 %

of patients report improved efficacy of actiTENS in reducing pain compared to other TENS used.

Control of actiTENS via a mobile application enables us to carry out real-life surveys with patients to assess the device's effectiveness

Our mission is

To develop and offer sustainable, clinically-supported drug-free therapeutic solutions to improve quality of life and support pain sufferers worldwide.

Our location

137 rue mayoussard,
38430 Moirans FRANCE

Contact our support

Mobile : +1 (865) 748-8562
Phone : +33 (0) 4 76 37 17 58
E-mail : contactUS@sublimed-technologies.com

Patient 1

Super device, I'm extremely satisfied with it, I use it every day for at least 3 hours, my neuropathic post-chemotherapy pain has halved. Thanks to this device, I've considerably reduced my consumption of painkillers. What's more, the helpline is really top-notch, very responsive and guarantees user satisfaction. I couldn't do without it, and I highly recommend it.

Patient 2

I've been using the actiTENS since September 2018. Almost 6 years of use without a single breakdown, which is rare reliability these days. It's a real marvel and has quickly become indispensable. The application is easy to use, the equipment extremely efficient, and, above all, very discreet. With numerous programs and remarkable autonomy, I highly recommend it to people who need to return to work and want to continue their daily care routine.

Patient 3

Super device and super app, which allow me both to combat my chronic pain and to passively strengthen certain muscles. The equipment is top-quality and modern, and the device can be controlled via the app. Customer service is also top-notch. I'm very satisfied.

Patient 4

CEO Scraft

Very intuitive to use. actiTENS electrodes are highly effective and, unlike others, can be used for longer periods of time. Very light and discreet, for use anywhere. Well done! I recommend this treatment device.

Patient 5

Very intuitive to use. actiTENS electrodes are highly effective and, unlike others, can be used for longer periods of time. Very light and discreet, for use anywhere. Well donThis product is truly revolutionary, I don’t need to shoot up with painkillers anymore... The application is very easy to use and the after-sales service is very efficient. I highly recommend this product!

What Our Patients Said

We have more than reviews on our store, join us in our commitment to a pain-free world !

Sources

The InApp survey conducted from 03/17 to 04/10/23 among 127 patients using actiTENS for the management of endometriosis pain showed that 61% of patients reported a reduction in medication consumption.
The inApp survey conducted from 10/21 to 11/25/21 among 183 patients using actiTENS for the relief of various types of pain showed that 79% of patients noted an improvement in their quality of life.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319385/
https://www.medpagetoday.com/resource-centers/clinical-challenges-knee-osteoarthritis
actiTENS, as a pain management solution, has undergone extensive clinical study (Etude Maheu – https://www.oarsijournal.com/article/S1063-4584(21)00599-9/fulltext). We remain committed to ongoing research to scientifically support its effectiveness in pain management.
https://www.who.int/news-room/fact-sheets/detail/endometriosis
https://pmc.ncbi.nlm.nih.gov/articles/PMC10241351/#:~:text=of%20women%20interviewed.-,Results,most%20commonly%20reported%20endometriosis%20symptoms.
InApp survey conducted from 31/05 to 26/06/23 among 68 patients new users of actiTENS suffering from various pathologies and having previously used another TENS

actiTENS® has been cleared by the FDA (510(k): K202159) in December 2020. actiTENS® is a medical device subject to contraindications. Please carefully read the actiTENS® manual before use.

Instructions for use

Prescription guide

Download Our App

Explore an innovative approach to pain relief by downloading the actiTENS app now!

SAS Sublimed 813 959 012 00010 – 137 rue Mayoussard 38430 Moirans – France – RCS Grenoble – Ref : SBM1AM021_US_V2 – Jan 2025